3 active warrant series covering 14,486,334 shares (~31.2% potential dilution); nearest expiry 2027-02-28.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.30 | Feb 28, 2027 164d | 4.9M | OTM | 10.6% | C$1.5M | Auto |
| warrant | $0.40 | Nov 27, 2027 436d | 853K | OTM | 1.8% | C$341K | Auto |
| warrant | $0.07 | May 16, 2028 607d | 8.7M | ITM | 18.8% | C$610K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
3 option grants covering 2,666,668 shares (~5.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $3.84 | Apr 14, 2027 209d | 167K | OTM | 0.4% | C$640K | Auto |
| option | $0.26 | Nov 7, 2027 416d | 250K | OTM | 0.5% | C$64K | Auto |
| option | $0.15 | May 27, 2030 1348d | 2.3M | OTM | 4.8% | C$338K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
46,482,245 shares outstanding, plus 14,486,334 from warrants and 2,666,668 from options — a fully diluted 63,635,247 shares, or ~36.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
3 active warrant series covering 14,486,334 shares (~31.2% potential dilution); nearest expiry 2027-02-28.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.30 | Feb 28, 2027 164d | 4.9M | OTM | 10.6% | C$1.5M | Auto |
| warrant | $0.40 | Nov 27, 2027 436d | 853K | OTM | 1.8% | C$341K | Auto |
| warrant | $0.07 | May 16, 2028 607d | 8.7M | ITM | 18.8% | C$610K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
3 option grants covering 2,666,668 shares (~5.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $3.84 | Apr 14, 2027 209d | 167K | OTM | 0.4% | C$640K | Auto |
| option | $0.26 | Nov 7, 2027 416d | 250K | OTM | 0.5% | C$64K | Auto |
| option | $0.15 | May 27, 2030 1348d | 2.3M | OTM | 4.8% | C$338K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
46,482,245 shares outstanding, plus 14,486,334 from warrants and 2,666,668 from options — a fully diluted 63,635,247 shares, or ~36.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
